Genetic predisposition to lung cancer

Comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies

Junjun Wang, Qingyun Liu, Shuai Yuan, Weijia Xie, Yuan Liu, Ying Xiang, Na Wu, Long Wu, Xiangyu Ma, Tongjian Cai, Yao Zhang, Zhifu D Sun, Yafei Li

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

More than 1000 candidate-gene association studies on genetic susceptibility to lung cancer have been published over the last two decades but with few consensuses for the likely culprits. We conducted a comprehensive review, meta-analysis and evidence strength evaluation of published candidate-gene association studies in lung cancer up to November 1, 2015. The epidemiological credibility of cumulative evidence was assessed using the Venice criteria. A total of 1018 publications with 2910 genetic variants in 754 different genes or chromosomal loci were eligible for inclusion. Main meta-analyses were performed on 246 variants in 138 different genes. Twenty-two variants from 21 genes (APEX1 rs1130409 and rs1760944, ATM rs664677, AXIN2 rs2240308, CHRNA3 rs6495309, CHRNA5 rs16969968, CLPTM1L rs402710, CXCR2 rs1126579, CYP1A1 rs4646903, CYP2E1 rs6413432, ERCC1 rs11615, ERCC2 rs13181, FGFR4 rs351855, HYKK rs931794, MIR146A rs2910164, MIR196A2 rs11614913, OGG1 rs1052133, PON1 rs662, REV3L rs462779, SOD2 rs4880, TERT rs2736098, and TP53 rs1042522) showed significant associations with lung cancer susceptibility with strong cumulative epidemiological evidence. No significant associations with lung cancer risk were found for other 150 variants in 98 genes; however, seven variants demonstrated strong cumulative evidence. Our findings provided the most updated summary of genetic risk effects on lung cancer and would help inform future research direction.

Original languageEnglish (US)
Article number8371
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Genetic Association Studies
Genetic Predisposition to Disease
Meta-Analysis
Lung Neoplasms
Genes
Cytochrome P-450 CYP2E1
Cytochrome P-450 CYP1A1
Publications

ASJC Scopus subject areas

  • General

Cite this

Genetic predisposition to lung cancer : Comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies. / Wang, Junjun; Liu, Qingyun; Yuan, Shuai; Xie, Weijia; Liu, Yuan; Xiang, Ying; Wu, Na; Wu, Long; Ma, Xiangyu; Cai, Tongjian; Zhang, Yao; Sun, Zhifu D; Li, Yafei.

In: Scientific Reports, Vol. 7, No. 1, 8371, 01.12.2017.

Research output: Contribution to journalArticle

Wang, Junjun ; Liu, Qingyun ; Yuan, Shuai ; Xie, Weijia ; Liu, Yuan ; Xiang, Ying ; Wu, Na ; Wu, Long ; Ma, Xiangyu ; Cai, Tongjian ; Zhang, Yao ; Sun, Zhifu D ; Li, Yafei. / Genetic predisposition to lung cancer : Comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{ccf2f000245847fb892c0242f1e37741,
title = "Genetic predisposition to lung cancer: Comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies",
abstract = "More than 1000 candidate-gene association studies on genetic susceptibility to lung cancer have been published over the last two decades but with few consensuses for the likely culprits. We conducted a comprehensive review, meta-analysis and evidence strength evaluation of published candidate-gene association studies in lung cancer up to November 1, 2015. The epidemiological credibility of cumulative evidence was assessed using the Venice criteria. A total of 1018 publications with 2910 genetic variants in 754 different genes or chromosomal loci were eligible for inclusion. Main meta-analyses were performed on 246 variants in 138 different genes. Twenty-two variants from 21 genes (APEX1 rs1130409 and rs1760944, ATM rs664677, AXIN2 rs2240308, CHRNA3 rs6495309, CHRNA5 rs16969968, CLPTM1L rs402710, CXCR2 rs1126579, CYP1A1 rs4646903, CYP2E1 rs6413432, ERCC1 rs11615, ERCC2 rs13181, FGFR4 rs351855, HYKK rs931794, MIR146A rs2910164, MIR196A2 rs11614913, OGG1 rs1052133, PON1 rs662, REV3L rs462779, SOD2 rs4880, TERT rs2736098, and TP53 rs1042522) showed significant associations with lung cancer susceptibility with strong cumulative epidemiological evidence. No significant associations with lung cancer risk were found for other 150 variants in 98 genes; however, seven variants demonstrated strong cumulative evidence. Our findings provided the most updated summary of genetic risk effects on lung cancer and would help inform future research direction.",
author = "Junjun Wang and Qingyun Liu and Shuai Yuan and Weijia Xie and Yuan Liu and Ying Xiang and Na Wu and Long Wu and Xiangyu Ma and Tongjian Cai and Yao Zhang and Sun, {Zhifu D} and Yafei Li",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-07737-0",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Genetic predisposition to lung cancer

T2 - Comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies

AU - Wang, Junjun

AU - Liu, Qingyun

AU - Yuan, Shuai

AU - Xie, Weijia

AU - Liu, Yuan

AU - Xiang, Ying

AU - Wu, Na

AU - Wu, Long

AU - Ma, Xiangyu

AU - Cai, Tongjian

AU - Zhang, Yao

AU - Sun, Zhifu D

AU - Li, Yafei

PY - 2017/12/1

Y1 - 2017/12/1

N2 - More than 1000 candidate-gene association studies on genetic susceptibility to lung cancer have been published over the last two decades but with few consensuses for the likely culprits. We conducted a comprehensive review, meta-analysis and evidence strength evaluation of published candidate-gene association studies in lung cancer up to November 1, 2015. The epidemiological credibility of cumulative evidence was assessed using the Venice criteria. A total of 1018 publications with 2910 genetic variants in 754 different genes or chromosomal loci were eligible for inclusion. Main meta-analyses were performed on 246 variants in 138 different genes. Twenty-two variants from 21 genes (APEX1 rs1130409 and rs1760944, ATM rs664677, AXIN2 rs2240308, CHRNA3 rs6495309, CHRNA5 rs16969968, CLPTM1L rs402710, CXCR2 rs1126579, CYP1A1 rs4646903, CYP2E1 rs6413432, ERCC1 rs11615, ERCC2 rs13181, FGFR4 rs351855, HYKK rs931794, MIR146A rs2910164, MIR196A2 rs11614913, OGG1 rs1052133, PON1 rs662, REV3L rs462779, SOD2 rs4880, TERT rs2736098, and TP53 rs1042522) showed significant associations with lung cancer susceptibility with strong cumulative epidemiological evidence. No significant associations with lung cancer risk were found for other 150 variants in 98 genes; however, seven variants demonstrated strong cumulative evidence. Our findings provided the most updated summary of genetic risk effects on lung cancer and would help inform future research direction.

AB - More than 1000 candidate-gene association studies on genetic susceptibility to lung cancer have been published over the last two decades but with few consensuses for the likely culprits. We conducted a comprehensive review, meta-analysis and evidence strength evaluation of published candidate-gene association studies in lung cancer up to November 1, 2015. The epidemiological credibility of cumulative evidence was assessed using the Venice criteria. A total of 1018 publications with 2910 genetic variants in 754 different genes or chromosomal loci were eligible for inclusion. Main meta-analyses were performed on 246 variants in 138 different genes. Twenty-two variants from 21 genes (APEX1 rs1130409 and rs1760944, ATM rs664677, AXIN2 rs2240308, CHRNA3 rs6495309, CHRNA5 rs16969968, CLPTM1L rs402710, CXCR2 rs1126579, CYP1A1 rs4646903, CYP2E1 rs6413432, ERCC1 rs11615, ERCC2 rs13181, FGFR4 rs351855, HYKK rs931794, MIR146A rs2910164, MIR196A2 rs11614913, OGG1 rs1052133, PON1 rs662, REV3L rs462779, SOD2 rs4880, TERT rs2736098, and TP53 rs1042522) showed significant associations with lung cancer susceptibility with strong cumulative epidemiological evidence. No significant associations with lung cancer risk were found for other 150 variants in 98 genes; however, seven variants demonstrated strong cumulative evidence. Our findings provided the most updated summary of genetic risk effects on lung cancer and would help inform future research direction.

UR - http://www.scopus.com/inward/record.url?scp=85027875413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027875413&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-07737-0

DO - 10.1038/s41598-017-07737-0

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 8371

ER -